International AIDS Society Conference

July 17-20, 2011 - Rome, Italy

Back IAS 2011

IAS 2011: HIV Treatment In Primary Infection: 48 Week Course Modestly Delays CD4 Drop

A 48-week course of antiretroviral treatment started within six months of becoming infected modestly delays the need for lifelong treatment, reported Sarah Fidler of Imperial College, London, at the 6th International AIDS Society Conference (IAS 2011) in Rome.alt

Read more:

IAS 2011: Poor CD4 Cell Recovery after Starting HIV Treatment Should Be a Cause For Concern

Patients whose CD4 cell count does not recover despite achieving virologic control with HIV therapy require continued medical attention, results of a large European study presented to the recent International AIDS Society conference (IAS 2011) in Rome show.alt

Read more:

IAS 2011: Hormonal Contraceptive Use Increases Women’s Risk of Acquiring and Transmitting HIV

A two-year, seven-country study has concluded that women using hormonal contraceptives, particularly injectable forms, are at a greater risk both of acquiring HIV themselves and of passing it on to a male sexual partner.alt

Read more:

IAS 2011: Maraviroc Improves Liver Fibrosis in HIV/Hepatitis C Coinfected Patients

Treatment with maraviroc is associated with the regression of liver fibrosis in HIV-positive patients co-infected with hepatitis C, a small randomised study presented to the Sixth International AIDS Society conference (IAS 2011) in Rome shows.alt

Read more:

IAS 2011: Inflammation Markers Linked to Liver Disease, Death in HIV/HBV and HIV/HCV Coinfection

Various blood biomarkers associated with immune activation and inflammation predicted liver flares, fibrosis progression, and death among HIV positive people coinfected with hepatitis B or C, according to 2 studies presented last month at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) in Rome.


Read more: